Cultivated meat deep dive: After the crash, who’s still standing?

It’s fair to say that cultivated meat is now well past its honeymoon period after a string of high-profile failures. But…

RQ Bio raises $115m for long-acting flu antibody

Why it matters: RQ Bio’s lead programme, RQB01, currently in IND-enabling studies, could establish a new pillar for influenza prophylaxis in vulnerable patient populations.

World Food Safety Day / Nigerian Food Manufacturer Celebrates Under Theme Of “From Burden To Solutions”

June 2026, US: Dios-Dlite, a food manufacturing company in Nigeria, participated in the global commemoration of World Fo…

World Food Safety Day / Weeklong Community Based Awareness For Food Safety

June 2026, US: Over the years, the HACCP Academy Nigeria (HAN) has commemorated World Food Safety Day through a unique w…

CAC49 / The Road to the 49th Commission Meeting

June 2026, US: The 49th session of the Codex Alimentarius Commission (CAC) is just around the corner and, with it, a swa…

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

SAN DIEGO — Biotechnology is entering one of the most transformative periods in its history. But, according to Biotechnology Innovation Organization (BIO) CEO John Crowley, outdated regulations, rising development costs, and global competition threaten to slow progress unless policymakers act.

Scaling Stem-Cell Manufacturing for Therapies

By Mike May, PhD Credit: Image generated with Google GeminiHuman pluripotent stem cells (hPSCs) have long been viewed as one of regenerative medicine’s most promising raw materials. Now, as more than 100 clinical trials evaluate hPSC-derived therapies for diseases ranging from Parkinson’s disease to heart failure and type 1 diabetes, attention is turning toward a crucial challenge: how to manufacture these cells reliably and economically at industrial scale.

Medra Launches Reasoning Layer for Drug Discovery Robotics

As AI infrastructure for drug discovery continues to proliferate with reasoning workflows capable of generating hypotheses, candidate molecules, and experimental plans, Medra CEO Michelle Lee, PhD, argues that physical AI is the solution to addressing the next bottleneck: experimental validation at scale.  

California Still Golden Despite Job Losses: Industry Group

SAN DIEGO—California’s three life sciences clusters all lost jobs last year, yet the industry remains a major engine of innovation and economic growth, according to a report released by the state’s largest life sciences organization to coincide with the Biotechnology Industry Organization (BIO) International Convention being held here.

Nvidia Unveils Science Reasoning AI Suite with BioNeMo Agent Toolkit

Credit: NvidiaNvidia has announced the NVIDIA BioNeMo Agent Toolkit, which turns complex scientific workflows into agent-executable tasks, including model selection, input preparation, workflow execution, output inspection, and results explanation.